Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-03

Clinical Trial Update: Lymph Node Microenvironment Modifications in Patients With CLL Treated With Venetoclax-based Regimens [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating lymph node microenvironment changes in chronic lymphocytic leukemia patients treated with venetoclax-based regimens.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • venetoclax-based regimens (venetoclax)

Snippet

Sponsor: Paolo Ghia | Conditions: Chronic Lymphocytic Leukemia | Phase 4 | Status: NOT_YET_RECRUITING